This cohort study, conducted within the Women's Health Initiative, examined the relationship between inflammatory biomarkers, hormone replacement therapy (HRT), and coronary heart disease (CHD) risk in postmenopausal women. Among 304 CHD cases and 304 matched controls, elevated baseline levels of C-reactive protein (CRP) and interleukin-6 (IL-6) were significantly associated with
